Home The Word Brain Fast Track My Amedeo FAQ About Flying Publisher   

Fast Track

Ear2MemoryFree App | Free PDF | Web
Learning languages on your smartphone
By BSK

Free Abstracts

  Breast Cancer

  Free Subscription


25.09.2017

1 Am J Surg
1 Am J Surg Pathol
2 Ann Oncol
1 Ann Surg
2 Ann Surg Oncol
4 Anticancer Res
1 BMC Cancer
4 Br J Cancer
7 Breast Cancer Res Treat
2 Breast J
1 Cancer
2 Cancer Lett
1 Carcinogenesis
2 Clin Breast Cancer
3 Eur J Cancer
1 Eur J Surg Oncol
1 Int J Cancer
1 J Clin Oncol
2 J Natl Cancer Inst
1 J Nucl Med
2 Lancet Oncol
2 Oncogene
3 PLoS One
1 Proc Natl Acad Sci U S A
1 Semin Oncol


  Retrieve available abstracts of this week’s articles:
HTML format
Text format
 
 
Single Articles


    Am J Surg

  1. ABBOTT AM, Valente SA, Loftus L, Tendulkar RD, et al
    A multi-institutional analysis of intraoperative radiotherapy for early breast cancer: Does age matter?
    Am J Surg. 2017;214:629-633.
    PubMed     Text format     Abstract available


    Am J Surg Pathol

  2. CHENG E, Ko D, Nguyen M, Moo TA, et al
    Residual Pure Intralymphatic Breast Carcinoma Following Neoadjuvant Chemotherapy Is Indicative of Poor Clinical Outcome, Even in Node-Negative Patients.
    Am J Surg Pathol. 2017;41:1275-1282.
    PubMed     Text format     Abstract available


    Ann Oncol

  3. HAMY AS, Pierga JY, Sabaila A, Laas E, et al
    Stromal lymphocyte infiltration after neoadjuvant chemotherapy is associated with aggressive residual disease and lower disease-free survival in HER2-positive breast cancer.
    Ann Oncol. 2017;28:2233-2240.
    PubMed     Text format     Abstract available

  4. REGAN MM, Walley BA, Francis PA, Fleming GF, et al
    Concurrent and sequential initiation of ovarian function suppression with chemotherapy in premenopausal women with endocrine-responsive early breast cancer: an exploratory analysis of TEXT and SOFT.
    Ann Oncol. 2017;28:2225-2232.
    PubMed     Text format     Abstract available


    Ann Surg

  5. MORROW M, Van Zee KJ, Patil S, Petruolo O, et al
    Axillary Dissection and Nodal Irradiation Can Be Avoided for Most Node-positive Z0011-eligible Breast Cancers: A Prospective Validation Study of 793 Patients.
    Ann Surg. 2017;266:457-462.
    PubMed     Text format     Abstract available


    Ann Surg Oncol

  6. GENTILE LF, Plitas G, Zabor EC, Stempel M, et al
    Tumor Biology Predicts Pathologic Complete Response to Neoadjuvant Chemotherapy in Patients Presenting with Locally Advanced Breast Cancer.
    Ann Surg Oncol. 2017 Sep 15. doi: 10.1245/s10434-017-6085.
    PubMed     Text format     Abstract available

  7. ZHANG Y, Seely J, Cordeiro E, Hefler J, et al
    Radioactive Seed Localization Versus Wire-Guided Localization for Nonpalpable Breast Cancer: A Cost and Operating Room Efficiency Analysis.
    Ann Surg Oncol. 2017 Sep 14. doi: 10.1245/s10434-017-6084.
    PubMed     Text format     Abstract available


    Anticancer Res

  8. UEHARA S, Saito K, Asami H, Ohta Y, et al
    Role of ARHGAP24 in ADP Ribosylation Factor 6 (ARF6)-dependent Pseudopod Formation in Human Breast Carcinoma Cells.
    Anticancer Res. 2017;37:4837-4844.
    PubMed     Text format     Abstract available

  9. FUJII T, Yanai K, Tokuda S, Nakazawa Y, et al
    Clinicopathological Features of Ductal Carcinoma In Situ from 18F-FDG-PET Findings.
    Anticancer Res. 2017;37:5053-5056.
    PubMed     Text format     Abstract available

  10. EICHLER C, Abrar S, Puppe J, Arndt M, et al
    Detection of Ductal Carcinoma In Situ by Ultrasound and Mammography: Size-dependent Inaccuracy.
    Anticancer Res. 2017;37:5065-5070.
    PubMed     Text format     Abstract available

  11. ISHITOBI M, Fukui R, Hashimoto Y, Kittaka N, et al
    Safety for Repeat Lumpectomy Without Radiotherapy for Ipsilateral Breast Tumor Recurrence.
    Anticancer Res. 2017;37:5293-5299.
    PubMed     Text format     Abstract available


    BMC Cancer

  12. REITHMEIER A, Panizza E, Krumpel M, Orre LM, et al
    Tartrate-resistant acid phosphatase (TRAP/ACP5) promotes metastasis-related properties via TGFbeta2/TbetaR and CD44 in MDA-MB-231 breast cancer cells.
    BMC Cancer. 2017;17:650.
    PubMed     Text format     Abstract available


    Br J Cancer

  13. MORRELL S, Roder D, Taylor R
    Reply to 'Comment on 'Effect of population breast screening on breast cancer mortality up to 2005 in England and Wales: an individual-level cohort study''.
    Br J Cancer. 2017 Sep 21. doi: 10.1038/bjc.2017.
    PubMed     Text format    

  14. GREGOIRE C, Bragard I, Jerusalem G, Etienne AM, et al
    Group interventions to reduce emotional distress and fatigue in breast cancer patients: a 9-month follow-up pragmatic trial.
    Br J Cancer. 2017 Sep 19. doi: 10.1038/bjc.2017.
    PubMed     Text format     Abstract available

  15. SHARMA R, Huang X, Brekken RA, Schroit AJ, et al
    Detection of phosphatidylserine-positive exosomes for the diagnosis of early-stage malignancies.
    Br J Cancer. 2017;117:545-552.
    PubMed     Text format     Abstract available

  16. YE ZJ, Qiu HZ, Liang MZ, Liu ML, et al
    Effect of a mentor-based, supportive-expressive program, Be Resilient to Breast Cancer, on survival in metastatic breast cancer: a randomised, controlled intervention trial.
    Br J Cancer. 2017 Sep 19. doi: 10.1038/bjc.2017.
    PubMed     Text format     Abstract available


    Breast Cancer Res Treat

  17. KAUFMAN DI, Shah C, Vicini FA, Rizzi M, et al
    Erratum to: Utilization of bioimpedance spectroscopy in the prevention of chronic breast cancer-related lymphedema.
    Breast Cancer Res Treat. 2017 Sep 20. doi: 10.1007/s10549-017-4505.
    PubMed     Text format     Abstract available

  18. GIANNAKEAS V, Narod SA
    The expected benefit of preventive mastectomy on breast cancer incidence and mortality in BRCA mutation carriers, by age at mastectomy.
    Breast Cancer Res Treat. 2017 Sep 15. doi: 10.1007/s10549-017-4476.
    PubMed     Text format     Abstract available

  19. SIEGELMANN-DANIELI N, Katzir I, Landes JV, Segal Y, et al
    Does levonorgestrel-releasing intrauterine system increase breast cancer risk in peri-menopausal women? An HMO perspective.
    Breast Cancer Res Treat. 2017 Sep 14. doi: 10.1007/s10549-017-4491.
    PubMed     Text format     Abstract available

  20. RICE BA, Ver Hoeve ES, DeLuca AN, Esserman LJ, et al
    Registry study to assess hair loss prevention with the Penguin Cold Cap in breast cancer patients receiving chemotherapy.
    Breast Cancer Res Treat. 2017 Sep 18. doi: 10.1007/s10549-017-4506.
    PubMed     Text format     Abstract available

  21. NYROP KA, Deal AM, Lee JT, Muss HB, et al
    Weight gain in hormone receptor-positive (HR+) early-stage breast cancer: is it menopausal status or something else?
    Breast Cancer Res Treat. 2017 Sep 14. doi: 10.1007/s10549-017-4501.
    PubMed     Text format     Abstract available

  22. JEONG IJ, Lee SG, Kim YH, Ko BS, et al
    Characteristics and prognosis of breast cancer after liver or kidney transplantation.
    Breast Cancer Res Treat. 2017 Sep 15. doi: 10.1007/s10549-017-4504.
    PubMed     Text format     Abstract available

  23. LEON-FERRE RA, Polley MY, Liu H, Gilbert JA, et al
    Impact of histopathology, tumor-infiltrating lymphocytes, and adjuvant chemotherapy on prognosis of triple-negative breast cancer.
    Breast Cancer Res Treat. 2017 Sep 14. doi: 10.1007/s10549-017-4499.
    PubMed     Text format     Abstract available


    Breast J

  24. OTA K, Rivera C, Martin M
    Specimen mammography distorts margin status in patients undergoing breast conserving surgery for early-stage breast cancer.
    Breast J. 2017 Sep 15. doi: 10.1111/tbj.12920.
    PubMed     Text format    

  25. BIGNON L, Fricker JP, Nogues C, Mouret-Fourme E, et al
    Efficacy of anthracycline/taxane-based neo-adjuvant chemotherapy on triple-negative breast cancer in BRCA1/BRCA2 mutation carriers.
    Breast J. 2017 Sep 19. doi: 10.1111/tbj.12887.
    PubMed     Text format     Abstract available


    Cancer

  26. HARTMAN SJ, Nelson SH, Myers E, Natarajan L, et al
    Randomized controlled trial of increasing physical activity on objectively measured and self-reported cognitive functioning among breast cancer survivors: The memory & motion study.
    Cancer. 2017 Sep 19. doi: 10.1002/cncr.30987.
    PubMed     Text format     Abstract available


    Cancer Lett

  27. WANG S, Zhou R, Sun F, Li R, et al
    The two novel DLL4-targeting antibody-drug conjugates MvM03 and MGD03 show potent anti-tumour activity in breast cancer xenograft models.
    Cancer Lett. 2017 Sep 15. pii: S0304-3835(17)30551.
    PubMed     Text format     Abstract available

  28. FIGUEIRA MI, Cardoso HJ, Correia S, Maia CJ, et al
    The stem cell factor (SCF)/c-KIT system in carcinogenesis of reproductive tissues: What does the hormonal regulation tell us?
    Cancer Lett. 2017;405:10-21.
    PubMed     Text format     Abstract available


    Carcinogenesis

  29. YANG F, Wang Y, Li Q, Cao L, et al
    Intratumor heterogeneity predicts metastasis of triple-negative breast cancer.
    Carcinogenesis. 2017;38:900-909.
    PubMed     Text format     Abstract available


    Clin Breast Cancer

  30. CID S, Eiro N, Fernandez B, Sanchez R, et al
    Prognostic Influence of Tumor Stroma on Breast Cancer Subtypes.
    Clin Breast Cancer. 2017 Aug 19. pii: S1526-8209(17)30189.
    PubMed     Text format     Abstract available

  31. CHAMP CE, Ohri N, Klement RJ, Cantor M, et al
    Assessing Changes in the Activity Levels of Breast Cancer Patients During Radiation Therapy.
    Clin Breast Cancer. 2017 Aug 24. pii: S1526-8209(17)30285.
    PubMed     Text format     Abstract available


    Eur J Cancer

  32. LOIBL S, de la Pena L, Nekljudova V, Zardavas D, et al
    Neoadjuvant buparlisib plus trastuzumab and paclitaxel for women with HER2+ primary breast cancer: A randomised, double-blind, placebo-controlled phase II trial (NeoPHOEBE).
    Eur J Cancer. 2017;85:133-145.
    PubMed     Text format     Abstract available

  33. RAPHAEL J, Helou J, Pritchard KI, Naimark DM, et al
    Palbociclib in hormone receptor positive advanced breast cancer: A cost-utility analysis.
    Eur J Cancer. 2017;85:146-154.
    PubMed     Text format     Abstract available

  34. XIE ZM, Sun J, Hu ZY, Wu YP, et al
    Survival outcomes of patients with lobular carcinoma in situ who underwent bilateral mastectomy or partial mastectomy.
    Eur J Cancer. 2017;82:6-15.
    PubMed     Text format     Abstract available


    Eur J Surg Oncol

  35. MARTELLI G, Miceli R, Folli S, Guzzetti E, et al
    Sentinel node biopsy after primary chemotherapy in cT2 N0/1 breast cancer patients: Long-term results of a retrospective study.
    Eur J Surg Oncol. 2017 Aug 10. pii: S0748-7983(17)30607.
    PubMed     Text format     Abstract available


    Int J Cancer

  36. DE GOOIJER MC, Zhang P, Weijer R, Buil LCM, et al
    The impact of P-glycoprotein and Breast Cancer Resistance Protein on the brain pharmacokinetics and pharmacodynamics of a panel of MEK inhibitors.
    Int J Cancer. 2017 Sep 16. doi: 10.1002/ijc.31052.
    PubMed     Text format     Abstract available


    J Clin Oncol

  37. IGLAY K, Santorelli ML, Hirshfield KM, Williams JM, et al
    Impact of Preexisting Mental Illness on All-Cause and Breast Cancer-Specific Mortality in Elderly Patients With Breast Cancer.
    J Clin Oncol. 2017 Sep 21:JCO2017734947. doi: 10.1200/JCO.2017.73.4947.
    PubMed     Text format     Abstract available


    J Natl Cancer Inst

  38. BLOK EJ, Kroep JR, Meershoek-Klein Kranenbarg E, Duijm-de Carpentier M, et al
    Optimal Duration of Extended Adjuvant Endocrine Therapy for Early Breast Cancer; Results of the IDEAL Trial (BOOG 2006-05).
    J Natl Cancer Inst. 2018;110.
    PubMed     Text format     Abstract available

  39. GOLDVASER H, Barnes TA, Seruga B, Cescon DW, et al
    Toxicity of Extended Adjuvant Therapy With Aromatase Inhibitors in Early Breast Cancer: A Systematic Review and Meta-analysis.
    J Natl Cancer Inst. 2018;110.
    PubMed     Text format     Abstract available


    J Nucl Med

  40. VENEMA CM, Mammatas LH, Schroder CP, van Kruchten M, et al
    Androgen and estrogen receptor imaging in metastatic breast cancer patients as a surrogate for tissue biopsies.
    J Nucl Med. 2017 Sep 14. pii: jnumed.117.193649. doi: 10.2967/jnumed.117.193649.
    PubMed     Text format     Abstract available


    Lancet Oncol

  41. KERR J, Anderson C, Lippman SM
    Physical activity, sedentary behaviour, diet, and cancer: an update and emerging new evidence.
    Lancet Oncol. 2017;18:e457-e471.
    PubMed     Text format     Abstract available

  42. LEVIS BE, Binkley PF, Shapiro CL
    Cardiotoxic effects of anthracycline-based therapy: what is the evidence and what are the potential harms?
    Lancet Oncol. 2017;18:e445-e456.
    PubMed     Text format     Abstract available


    Oncogene

  43. XIA L, Xiao X, Liu WL, Song Y, et al
    Coactosin-like protein CLP/Cotl1 suppresses breast cancer growth through activation of IL-24/PERP and inhibition of non-canonical TGFbeta signaling.
    Oncogene. 2017 Sep 18. doi: 10.1038/onc.2017.
    PubMed     Text format     Abstract available

  44. YAMAGUCHI H, Du Y, Nakai K, Ding M, et al
    EZH2 contributes to the response to PARP inhibitors through its PARP-mediated poly-ADP ribosylation in breast cancer.
    Oncogene. 2017 Sep 18. doi: 10.1038/onc.2017.
    PubMed     Text format     Abstract available


    PLoS One

  45. GOTZ TI, Lahmer G, Strnad V, Bert C, et al
    A tool to automatically analyze electromagnetic tracking data from high dose rate brachytherapy of breast cancer patients.
    PLoS One. 2017;12:e0183608.
    PubMed     Text format     Abstract available

  46. PARK NJ, Chang Y, Bender C, Conley Y, et al
    Cardiovascular disease and mortality after breast cancer in postmenopausal women: Results from the Women's Health Initiative.
    PLoS One. 2017;12:e0184174.
    PubMed     Text format     Abstract available

  47. BUONOMO OC, Caredda E, Portarena I, Vanni G, et al
    New insights into the metastatic behavior after breast cancer surgery, according to well-established clinicopathological variables and molecular subtypes.
    PLoS One. 2017;12:e0184680.
    PubMed     Text format     Abstract available


    Proc Natl Acad Sci U S A

  48. HE F, Chiou AE, Loh HC, Lynch M, et al
    Multiscale characterization of the mineral phase at skeletal sites of breast cancer metastasis.
    Proc Natl Acad Sci U S A. 2017 Sep 18. pii: 201708161.
    PubMed     Text format     Abstract available


    Semin Oncol

  49. O'SULLIVAN CC, Davarpanah NN, Abraham J, Bates SE, et al
    Current challenges in the management of breast cancer brain metastases.
    Semin Oncol. 2017;44:85-100.
    PubMed     Text format     Abstract available


Thank you for your interest in scientific medicine.


AMEDEO Breast Cancer is free of charge.
This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim.

Design: